Company Filing History:
Years Active: 1990
Title: Helene Cabrillat: Innovator in Monoclonal Antibodies
Introduction
Helene Cabrillat is a prominent inventor based in Lyon, France. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work has implications for various therapeutic applications, showcasing her expertise and dedication to scientific advancement.
Latest Patents
Helene Cabrillat holds a patent for "Monoclonal antibodies to gamma-interferon, hybridomas producing such antibodies." This patent describes monoclonal antibodies that are preferably of the immunoglobulin subclass IgG1, kappa, and do not bind to interferon-alpha2. This innovation represents a crucial step in the development of targeted therapies.
Career Highlights
Cabrillat is associated with Laboratoires Unicet, where she has been instrumental in advancing research in immunology. Her work has not only contributed to the scientific community but has also paved the way for new treatment options in medicine.
Collaborations
Throughout her career, Helene Cabrillat has collaborated with notable colleagues, including Jacques F. Banchereau and Odile Djossou. These partnerships have enhanced her research and expanded the impact of her innovations.
Conclusion
Helene Cabrillat's contributions to the field of monoclonal antibodies exemplify her role as a leading inventor in biotechnology. Her work continues to influence the development of new therapeutic strategies, highlighting the importance of innovation in healthcare.